Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
IQMD was delisted on the 26th of April, 2023.
56 hedge funds and large institutions have $146M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
1,800% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 2
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
180% more funds holding
Funds holding: 20 → 56 (+36)
104% more capital invested
Capital invested by funds: $71.9M → $146M (+$74.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$9.93M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$6.97M |
| 3 |
LA
Linden Advisors
New York
|
+$6.95M |
| 4 |
SC
Sculptor Capital
New York
|
+$4.97M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$4.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$2.57M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$2.25M |
| 3 |
CS
Clear Street
New York
|
-$19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
51
Basso Capital Management
Stamford,
Connecticut
| $53K | +$52.5K | +5,288 | New |
|
|
AA
52
Ancora Advisors
Cleveland,
Ohio
| $50K | +$49.7K | +5,000 | New |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $3K | +$2.76K | +278 | New |
|
54
UBS Group
Zurich,
Switzerland
| $2K | +$2.09K | +210 | New |
|
|
PFS
55
Prospera Financial Services
Dallas,
Texas
| $1K | +$993 | +100 | New |
|
|
ASM
56
ATW SPAC Management
New York
| $315 | +$313K | +31,494 | New |
|
|
NAM
57
Nexpoint Asset Management
Dallas,
Texas
| – | -$2.57M | -260,000 | Closed |
|
|
CS
58
Clear Street
New York
| – | -$19K | -1,933 | Closed |
|
IQMD Hedge Fund Activity: Q1 2022 in Review
56 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q1 2022, worth a combined $146M — up 104% from $71.9M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new IQMD positions and 2 closed out — a net gain of 36 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was MMCAP International, opening a new position worth an estimated $9.93M. The largest seller was Nexpoint Asset Management, exiting entirely with an estimated $2.57M sold.
- 56 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q1 2022, up from 20 in Q4 2021.
- Funds reported $146M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q1 2022, up 104% quarter-over-quarter.
- 38 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q1 2022 and 2 closed out, a net change of +36 holders.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q1 2022 was MMCAP International, an estimated $9.93M added.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q1 2022 was Nexpoint Asset Management, an estimated $2.57M sold.
Based on aggregated 13F filings for Q1 2022.